Drugs / GHRP-3
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1/2 | NCT00846872 Comparator | Jul 2008 → Mar 2012 | — | Tulane University Health Sciences Center | Withdrawn | No outcome recorded Stop: Enrollment |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GHRP-3 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00846872 ↗ |
| Known as | Formerly coded as 1485 | “Formerly coded as 1485” NCT00846872 ↗ |
| Modality | Other / unclassified | “Fourth generation growth hormone secretagogue” NCT00846872 ↗ |
| Route | Subcutaneous | “will be infused subcutaneously” NCT00846872 ↗ |